`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2014‐00550
`Petitioner’s Updated Notice of Back‐Up Counsel
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`NOVEN PHARMACEUTICALS, INC.,
`
`Petitioner
`
`v.
`
`NOVARTIS AG AND LTS LOHMANN THERAPIE-SYSTEME AG,
`
`Patent Owners
`
`Inter Partes Review No.: IPR2014-00550
`U.S. Patent No. 6,335,031
`
`PETITIONER’S UPDATED NOTICE OF BACK-UP
` COUNSEL UNDER 37 C.F.R. § 42.8(b)(3)
`
`
`
`
`
`
`
`IPR2014‐00550
`Petitioner’s Updated Notice of Back‐Up Counsel
`
`
`PETITIONER’S UPDATED NOTICE OF BACK-UP
`COUNSEL UNDER 37 C.F.R. § 42.8(b)(3)
`Petitioner, Noven Pharmaceuticals, Inc., (“Noven”) hereby updates back-
`
`up counsel in the above-captioned Inter Partes Review:
`
`Lead Counsel
`Steven J. Lee
`(Reg. No. 31,272)
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`slee@kenyon.com
`Tel: 212-908-6305
`Fax: 212-425-5288
`
`Back-Up Counsel
`Michael K. Levy
`(Reg. No 40,699)
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`mlevy@kenyon.com
`Tel: 212-908-6221
`Fax: 212-425-5288
`
`The designation of Michael K. Levy replaces the prior designation of Cynthia
`
`Lambert Hardman as back-up counsel.
`
`Dated: September 26, 2014
`
`
`
`
`
`/Steven J. Lee/
`Steven J. Lee
`(Reg. No. 31,272)
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`slee@kenyon.com
`Tel: 212-908-6305
`Fax: 212-425-5288
`
`Counsel for Petitioner Noven Pharmaceuticals,
`Inc.
`
`
`
`
`
`
`
`
`
`
`
`IPR2014‐00550
`Petitioner’s Updated Notice of Back‐Up Counsel
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that “PETITIONER’S UPDATED
`
`NOTICE OF BACK-UP COUNSEL UNDER 37 C.F.R. § 42.8(b)(3)”
`
`electronically filed on September 26, 2014, in Inter Partes Review No. 2014-
`
`00550 in the United States Patent and Trademark Office (USPTO), was
`
`electronically served on Patent Owners:
`
`ExelonPatchIPR@fchs.com
`
`
`
`September 26, 2014
`
`/Steven J. Lee/
`Steven J. Lee
`
`
`
`